Piramal Pharma Ltd. Fundamental & Technical Research, Share Price Today

NSE : PPLPHARMA
NIFTY : Nifty 500

About Company

Piramal Pharma Limited (PPL) offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across several global facilities and a global distribution network in hundreds of countries. It includes Piramal Pharma Solutions (PPS), an integrated Contract Development and Manufacturing Organisation (CDMO), Piramal Critical Care (PCC), a Complex Hospital Generics business, and the India Consumer Healthcare business selling over-the-counter products. PPS offers end-to-end development and manufacturing solutions through a globally integrated network of facilities across the drug life cycle to innovators and generic companies. PCC’s complex hospital product portfolio includes inhalation anaesthetics, intrathecal therapies for spasticity and pain management, injectable pain and anaesthetics, injectable anti-infectives, and other therapies.

Market Cap. ₹ 27,161 Cr.

52 Week - High/Low ₹ 308/136

P/E Ratio 39.96

P/B Ratio 4.12

Enterprise Value ₹ 28,275 Cr.

ROE % 6.55

RSI Value 59.94

EMA 50 215.74

EMA 200 211.93

Market Cap. ₹ 27,161 Cr.

52 Week - High/Low ₹ 308/136

P/E Ratio 302.33

P/B Ratio 3.50

Enterprise Value ₹ 30,103 Cr.

ROE % 0.24

RSI Value 59.94

EMA 50 215.74

EMA 200 211.93

Add Parameters

Valuation

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages